Mostrar el registro sencillo del ítem
Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol
dc.contributor.author | Antezana, G | |
dc.contributor.author | Zeballos, R | |
dc.contributor.author | Mendoza, C | |
dc.contributor.author | Lyevre, P | |
dc.contributor.author | Valda, L | |
dc.contributor.author | Cárdenas, F | |
dc.contributor.author | Noriega, I | |
dc.contributor.author | Ugarte, H | |
dc.contributor.author | Dedet, P | |
dc.date.accessioned | 2017-09-14T13:30:47Z | |
dc.date.available | 2017-09-14T13:30:47Z | |
dc.date.issued | 1992 | |
dc.identifier.uri | http://repositorio.umsa.bo/xmlui/handle/123456789/12448 | |
dc.description.abstract | Abstract. The electrocardiographic (ECG) changes in Bolivian patients with mucocutaneous leishmaniasis, treated with meglumine antimoniate and allopurinol, were evaluated. Electric changes due to the antimonial compound appeared in 45% of the patients, and consisted of repolarization alteration, principally affecting the T wave and the S-T segment. The changes disappeared within 2 months following the end of the antimonial treatment. In patients with associated Chagas disease and leishmaniasis, antimonial therapy did not aggravate the ECG changes characteristic of Chagasic cardiopathy. | es_ES |
dc.language.iso | en | es_ES |
dc.publisher | Transantions of The Royal Society of Tropical Medicine and Hygiene | es_ES |
dc.subject | LEISHMANIASIS MUCOCUTÁNEA | es_ES |
dc.subject | ELECTROCARDIOGRAFÍA | es_ES |
dc.title | Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol | es_ES |
dc.type | Article | es_ES |